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Supplementary Results  
1.1. Seed based network connectivity patterns in the placebo and ketamine condition  
For seed based analysis of the default mode network connectivity, the PCC/precuneus area is 
used as a seed of interest. Performing a F-test for second level statistical analysis, a typical 
clustering of significant activation patterns is observed. The cluster covers areas including the 
medial prefrontal cortex, as well as left and right hemispheric parietal lobes and 
PCC/precuneus areas. Different connectivity patterns for the placebo and ketamine condition 
(Figure S1, two-sided F-statistic height threshold T>8.5, FWE corrected cluster threshold 
p<0.01) is observed, and shown in the main text body (result section, Figure 2). A detailed 
description of the significantly different activated brain regions for the contrast ketamine > 
placebo is presented in Table S1 (FWE corrected p=0.05).  
 
 
Figure S1 Activations shown are the intersections (axial, 6mm intersection distance) of the 
DMN z-transformed network maps of the placebo (a) and ketamine (b) condition (color coded 
T-values). Note the decrease of frontal connectivity and the increase of parietal connectivity 
to the PCC/precuneus (seed) area for ketamine condition.   
 
1.2 Gamma band activity measured with simultaneous EEG/MRI setup 
It is important to mention that gamma band activation of simultaneously measured EEG/fMRI 
data is contaminated by technical artifacts within a frequency range >30Hz.  Whereas the 
gradient artifact which is stable over time can be sufficiently removed by template subtraction 
methods, and the Helium-Pump artifact can be avoided by simply switching off the Helium-
pump like in our study, other artifacts like cardio ballistic artifacts (CBA) or artifacts from the 
internal ventilation system (4) are not that easy to handle. Currently developed technical 
solutions like simultaneous measurements with carbon wired loops (5) or multiband fMRI 
techniques (6), which would help to clean the data from such artifacts, were not developed at 
the time when we conducted the EEG/fMRI measurements. As common post processing 
algorithms cannot sufficiently clean the data from such artifacts (5), it is difficult to interpret 
differences in gamma band activity in simultaneously measured EEG/fMRI data. Therefore we 
decided to use filter settings with a relatively sharp cutoff at 45 Hz with a slope of 8db. This 
focused our analysis to frequencies lower than 50Hz since with our settings at less than 50 % 
of energy of frequencies > 50Hz remain (Figure S2). Nevertheless, this affects both conditions 
equally and so it could not explain the differences we had found between conditions.      
 
Figure S2 shows the remaining amount of EEG Power in percent after applied filter settings 
(zero phase shift Butterworth filters: order 4 low cutoff filter of 0.53Hz , order 8 high cutoff 
filter of 45Hz). Note that less than 50 % of EEG power for frequencies > 50Hz remain.  
1.3 Spectral edge frequency (SEF) 
Commonly, SEFs from frontal electrodes are used in anesthesiology, to assess the depth of 
anesthesia. SEF is defined as the frequency below which a certain amount of total power is 
concentrated (7, 8). For our analysis we use an amount of 90% of total power. SEF analysis 
was conducted for four different brain regions covering the head surface which were defined 
by electrode positions (frontal: FP1, FP2, F3, F4, F7, F8; temporo-central left hemisphere: T7, 
FC1, FC5, C3, CP1, CP; temporo-central right hemisphere: T8, FC2, FC6, C4, CP2, CP6; parieto-
occipital: TP9, TP10, P7, P8, P3, P4, Pz, O1, O2, Oz). The resulting individual mean SEFs were 
used for statistical analysis.  
Figure S3 show the mean SEF and SD for placebo (black) and ketamine (red) condition of 
frontal, parieto-occipital, temporo-central left and right brain regions. Two-Way Repeated 
Measure ANOVA gave significant differences in SEF with lower SEF for ketamine condition 
(SEFK, p < 0.017) in frontal brain regions and higher SEFK for parieto-occipital brain regions 
(p < 0.02). Temporo-central regions show no significant differences in SEF between drug 
conditions. It is well known that the EEG spectral edge frequency (SEF), measured with 
electrodes attached at frontal head positions, is decreasing with increasing anaesthesia and it 
is nowadays used as clinical marker for the depth of anaesthesia. Here we could show that 
such decrease in SEF is also true when applying ketamine in subanaesthetic doses. 
Furthermore, we found an increase in SEF for parietal-occipital brain regions, which normally 
is not detectable with standard clinical setups. One may consider this observation, when 
frontal electrode positions are not applicable for clinical monitoring and thus, when there is a 
need for using other electrode positions.  
  
 
Figure S3 mean SEF±SD for four different brain regions for placebo (black) and ketamine 
condition (red). Underlying data are SEFs of neighbouring electrode positions for frontal, 
parieto-occipital, temporo-central left and temporo-central right head surface areas based on 
the International 10-20 system. Significant differences between conditions could be shown 
only for frontal (p < 0.017) and parieto-occipital brain regions (p < 0.02), with lower and higher 
mean SEF for ketamine condition, respectively. 
1.4 Energy shifts from alpha2 to alpha1  
Purdon et al. (9) showed increased alpha power for frontal brain regions with increasing depth 
of anaesthesia. Although there are no differences between conditions in alpha FFTP, for 
ketamine condition an energy shift of FFTP to slower frequencies in between alpha is 
observable. Figure S4 (right part) shows a scatterplot of the geometric mean (GM) FFTP of 
alpha1 (red squares) or alpha2 (blue circles) plotted against the GM FFTP of alpha for placebo 
(open symbols) and ketamine (closed symbols) condition. The FFTP, GM data of all electrodes 
show no differences in the relationship of alpha1 to alpha (a1/a) and alpha 2 to alpha (a2/a) 
for placebo condition (Wilcoxon Signed Rank Test with paired samples, p = 0.81, Z = -0.25) but 
a statistically significant different distribution of the ratios a1/a and a2/a for ketamine 
condition (Wilcoxon signed rank Test with paired samples, p << 0.001, Z=-4.71). This is 
supported when performing linear model fitting of the data (Pearson´s R > 0.99) with 
comparable slopes m close to 1 (ma1/a = 0.95±0.02, ma2/a = 0.98±0.02) for placebo condition 
and different slopes ma1/a =1.09±0.02 and ma2/a = 0.85±0.02 for ketamine condition. For better 
visualization of the head distribution of the aforementioned energy shift, the left part of Figure 
3 shows heatmaps of FFTP ratios “alpha1 vs. alpha” and “alpha2 vs. alpha” for placebo and 
ketamine condition. An energy shift to alpha 1, namely increasing ratios > 1 for “alpha1 vs. 
alpha” and decreasing ratios < 1 for “alpha2 vs. alpha”, for ketamine condition in comparison 
to placebo condition could be seen, with mainly frontal, temporal and parietal regions 
involved.  
 
 
Figure S4 a-d) show heatmaps of FFTP ratios “alpha1 vs. alpha” (a-b) and “alpha2 vs. alpha” 
(c-d) for placebo (a, c) and ketamine (b, d) condition. e) Shows a scatterplot of GM FFTP of 
alpha1 (closed symbols) or alpha2 (open symbols) plotted against the GM FFTP of alpha for 
placebo (black) and ketamine (red) condition (lines were corresponding line fits).  
Of further interest, this increase in alpha1 power for ketamine condition is accompanied by 
increased fronto-parietal coherence of the right hemisphere, which cannot be equated with 
increased functional connectivity between anterior and posterior brain structures. 
 
1.5 Coherence analysis 
For analyzing the magnitude squared coherence between different electrodes, we used the 
power spectra of 15 electrode pairs of interest that are representative of connections within 
or between both hemispheres (intrahemispheric left hemisphere: F3C3, F3P3, F3T7, C3P3, 
C3T7, P3T7; intrahemispheric right hemisphere: F4C4, F4P4, F4T8, C4P4, C4T8, P4T8; 
interhemispheric: F3F4, C3C4, P3P4). 
alpha1 coherence analysis: Figure S5 plots the magnitude squared coherence between two 
electrodes as mean coherence values between 0 (low connectivity) and 1 (high connectivity) 
+ SD of alpha1 FFTP for placebo (black) and ketamine (red) condition. The plotted results were 
divided into interhemispheric and intrahemispheric electrode pairs. As shown in Figure S5 
ketamine leads to higher coherence values compared to placebo condition for right 
hemispheric electrode pairs. Similar effects for left hemispheric pairs could not be shown.  
Additionally statistical significant differences between conditions could be shown for the 
central interhemispheric electrode pair (C3-C4, p = 0.025, F = 6.12), but we have to mention 
the very small coherence values below 0.134. The other frequency bands show nearly no 
significant differences between conditions. 
 
Figure S5 Coherence analysis for inter- and intrahemispheric electrode pairs color-coded for 
conditions (placebo = black, ketamine = red). Bars + tickmarks represent mean + SD coherence 
between 0 (low connectivity) and 1 (high connectivity) for alpha1 FFTP. One-way repeated 
measure ANOVA gave significant differences (p<0.05) mainly for right hemispheric electrode 
pairs with higher coherences of ketamine condition. 
 
 
 
  
 
 
 
mPFC 240 voxels 9% of Cingulate Gyrus, anterior division 
 212 voxels 16% of Paracingulate Gyrus Left 
 190 voxels 19% of Frontal Medial Cortex 
 157 voxels 14% of Subcallosal Cortex 
 156 voxels 11% of Paracingulate Gyrus Right 
 45 voxels 1% of Frontal Pole Left 
 176 voxels not-labeled 
   
left IPL 393 voxels 27% of Superior Parietal Lobule Left 
 321 voxels 6% of Lateral Occipital Cortex, superior 
division Left 
 240 voxels 25% of Supramarginal Gyrus, anterior 
division Left 
 105 voxels 3% of Postcentral Gyrus Left 
 200 voxels not-labeled 
   
right IPL 219 voxels 15% of Superior Parietal Lobule Right 
 72 voxels 1% of Lateral Occipital Cortex, superior 
division Right 
 17 voxels 1% of Supramarginal Gyrus, posterior 
division Right 
 11 voxels Angular Gyrus Right or not labelled 
 
 
Table S1 shows the amount of FWE corrected significant voxels (two-sided, p = 0.05) for the 
contrast ketamine > placebo. The size of the related brain area in percent is based on Harvard 
Oxford Atlas. Brain regions which involve more than 15 % of an atlas region are highlighted in 
bold.     
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